{"title":"图书角","authors":"Peter L. McDermott","doi":"10.1080/15321810500220993","DOIUrl":null,"url":null,"abstract":"Industrial Proteomics, Applications for Biotechnology and Pharmaceuticals is as the editor states “is a focused treatment of industrial applications of proteomics. Proteomics in industry is generally focused on application in target discovery and pharmaceutical pipelines, thereby requiring proteomic processes that are robust, well characterized, under quality control (QC) and producing statistically significant results. It also requires the capacity to handle significant amounts of samples. For example, a simple clinical proteomic study might require an analysis by expression proteomics from a minimum of 36 to hundreds of complex samples.” This book contains 11 chapters, each of which addresses specific aspects of industrial application of proteomics. The first chapter covers the basics of mass spectrometry (MS)-based proteomics. Functional proteomics is covered in Chapters 2 and 3. Chapter 2 discusses the MS-based approaches of mapping protein interactions. Chapter 3 discusses the protein posttranslational modifications, particularly, protein phosphorylations. Structural proteomics is covered in Chapters 4 and 5. Chapter 4 covers the use of high-throughput crystallography and in silico methods for structure-based drug design. Chapter 5 describes the use of hydrogen/deuterium exchange mass spectrometry for high-throughput protein structure studies. The first applications of proteomics were in target discovery. Chapter 6, a discussion of the utilization of proteomics technologies for the identification as well as the validation of protein targets is given. The latest application of proteomics has been for the discovery of disease or drug-related biomarkers. Chapter 7 provides an overview of biomarker discovery and validation while Chapter 8 details plasma biomarker discovery using proteomics. Proteomics can also be approached from the small-molecule worked (i.e., drugs), particularly, to find proteins that interact with drugs. Chapter 9 presents chemical genomics/chemical proteomics and discusses the different approaches. Journal of Immunoassay & Immunochemistry, 26: 357–364, 2005 Copyright # Taylor & Francis, Inc. ISSN 1532-1819 print/1532-4230 online DOI: 10.1080/15321810500220993","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":"100 1","pages":"357 - 364"},"PeriodicalIF":0.0000,"publicationDate":"2005-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Book Corner\",\"authors\":\"Peter L. McDermott\",\"doi\":\"10.1080/15321810500220993\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Industrial Proteomics, Applications for Biotechnology and Pharmaceuticals is as the editor states “is a focused treatment of industrial applications of proteomics. Proteomics in industry is generally focused on application in target discovery and pharmaceutical pipelines, thereby requiring proteomic processes that are robust, well characterized, under quality control (QC) and producing statistically significant results. It also requires the capacity to handle significant amounts of samples. For example, a simple clinical proteomic study might require an analysis by expression proteomics from a minimum of 36 to hundreds of complex samples.” This book contains 11 chapters, each of which addresses specific aspects of industrial application of proteomics. The first chapter covers the basics of mass spectrometry (MS)-based proteomics. Functional proteomics is covered in Chapters 2 and 3. Chapter 2 discusses the MS-based approaches of mapping protein interactions. Chapter 3 discusses the protein posttranslational modifications, particularly, protein phosphorylations. Structural proteomics is covered in Chapters 4 and 5. Chapter 4 covers the use of high-throughput crystallography and in silico methods for structure-based drug design. Chapter 5 describes the use of hydrogen/deuterium exchange mass spectrometry for high-throughput protein structure studies. The first applications of proteomics were in target discovery. Chapter 6, a discussion of the utilization of proteomics technologies for the identification as well as the validation of protein targets is given. The latest application of proteomics has been for the discovery of disease or drug-related biomarkers. Chapter 7 provides an overview of biomarker discovery and validation while Chapter 8 details plasma biomarker discovery using proteomics. Proteomics can also be approached from the small-molecule worked (i.e., drugs), particularly, to find proteins that interact with drugs. Chapter 9 presents chemical genomics/chemical proteomics and discusses the different approaches. Journal of Immunoassay & Immunochemistry, 26: 357–364, 2005 Copyright # Taylor & Francis, Inc. ISSN 1532-1819 print/1532-4230 online DOI: 10.1080/15321810500220993\",\"PeriodicalId\":15987,\"journal\":{\"name\":\"Journal of Immunoassay and Immunochemistry\",\"volume\":\"100 1\",\"pages\":\"357 - 364\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Immunoassay and Immunochemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/15321810500220993\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Immunoassay and Immunochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15321810500220993","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
工业蛋白质组学,生物技术和制药的应用,正如编辑所说,是蛋白质组学的工业应用的重点治疗。蛋白质组学在工业上的应用通常集中在靶点发现和制药管道中,因此要求蛋白质组学过程是稳健的,具有良好的特征,在质量控制(QC)下,并产生统计上显著的结果。它还需要处理大量样品的能力。例如,一项简单的临床蛋白质组学研究可能需要对至少36到数百个复杂样本进行表达蛋白质组学分析。”本书包含11章,每一章都涉及蛋白质组学工业应用的具体方面。第一章涵盖了基于质谱(MS)的蛋白质组学的基础知识。功能蛋白质组学将在第2章和第3章中介绍。第2章讨论了基于质谱的蛋白质相互作用制图方法。第3章讨论了蛋白质的翻译后修饰,特别是蛋白质磷酸化。结构蛋白质组学将在第4章和第5章中介绍。第4章涵盖了高通量晶体学和基于结构的药物设计的硅方法的使用。第5章描述了氢/氘交换质谱法在高通量蛋白质结构研究中的应用。蛋白质组学的第一个应用是靶标发现。第六章讨论了蛋白质组学技术在蛋白质靶点鉴定和验证中的应用。蛋白质组学的最新应用是发现疾病或药物相关的生物标志物。第7章概述了生物标志物的发现和验证,而第8章详细介绍了使用蛋白质组学发现血浆生物标志物。蛋白质组学也可以从小分子工作(即药物)着手,特别是寻找与药物相互作用的蛋白质。第9章介绍了化学基因组学/化学蛋白质组学,并讨论了不同的方法。免疫分析与免疫化学杂志,26:357-364,2005版权所有# Taylor & Francis, Inc。ISSN 1532-1819 print/1532-4230 online DOI: 10.1080/15321810500220993
Industrial Proteomics, Applications for Biotechnology and Pharmaceuticals is as the editor states “is a focused treatment of industrial applications of proteomics. Proteomics in industry is generally focused on application in target discovery and pharmaceutical pipelines, thereby requiring proteomic processes that are robust, well characterized, under quality control (QC) and producing statistically significant results. It also requires the capacity to handle significant amounts of samples. For example, a simple clinical proteomic study might require an analysis by expression proteomics from a minimum of 36 to hundreds of complex samples.” This book contains 11 chapters, each of which addresses specific aspects of industrial application of proteomics. The first chapter covers the basics of mass spectrometry (MS)-based proteomics. Functional proteomics is covered in Chapters 2 and 3. Chapter 2 discusses the MS-based approaches of mapping protein interactions. Chapter 3 discusses the protein posttranslational modifications, particularly, protein phosphorylations. Structural proteomics is covered in Chapters 4 and 5. Chapter 4 covers the use of high-throughput crystallography and in silico methods for structure-based drug design. Chapter 5 describes the use of hydrogen/deuterium exchange mass spectrometry for high-throughput protein structure studies. The first applications of proteomics were in target discovery. Chapter 6, a discussion of the utilization of proteomics technologies for the identification as well as the validation of protein targets is given. The latest application of proteomics has been for the discovery of disease or drug-related biomarkers. Chapter 7 provides an overview of biomarker discovery and validation while Chapter 8 details plasma biomarker discovery using proteomics. Proteomics can also be approached from the small-molecule worked (i.e., drugs), particularly, to find proteins that interact with drugs. Chapter 9 presents chemical genomics/chemical proteomics and discusses the different approaches. Journal of Immunoassay & Immunochemistry, 26: 357–364, 2005 Copyright # Taylor & Francis, Inc. ISSN 1532-1819 print/1532-4230 online DOI: 10.1080/15321810500220993